IMM 1.69% 29.0¢ immutep limited

Overnight Market report, page-69

  1. 467 Posts.
    lightbulb Created with Sketch. 100
    G,day Vivo, IMO and investment strategy with Immutep is now the wait for FDA approval on Lag-3 in March for BMS . IMM is mostly focused on cancers but happy for any positive news left field. I think we will do well this year…

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.